Presentation TCT 2018 Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif September 22, 2018
Presentation TCT 2018 IABP in Cardiogenic Shock: Reconciling Clinical Trial Results and Guidelines With Real-World Experience (With Practical-use Recommendations) Presenter: Cindy L. Grines, E. Magnus Ohman, Richard Smalling September 22, 2018
Presentation TCT 2018 Most Important Clinical Trials in Vascular Medicine and Intervention in the Past 10 Years Presenter: Jay S. Giri, Sahil A. Parikh September 22, 2018
News Conference News TCT 2018 EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis Michael O'Riordan September 21, 2018
News Opinion Off Script TCT 2018 Off Script: Welcome to the 30th TCT 2018 in Sunny San Diego Kwan S. Lee September 21, 2018
Presentation TCT 2018 TCT-120: Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis from 21 Randomized Trials Presenter: Michael A. Kutcher, Tullio Palmerini, Ioanna Kosmidou September 21, 2018
Presentation TCT 2018 TCT-112: Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Event in the Global Leaders Trial Presenter: George D. Dangas, Germano Di Sciascio, Patrick W. Serruys September 21, 2018
Presentation TCT 2018 TCT-119: Impact of Clinical Syndrome on Outcomes After PCI: Analysis From a Large Pooled Randomized Trial Dataset Presenter: Michael A. Kutcher, Tullio Palmerini, Masaru Ishida September 21, 2018
Presentation TCT 2018 TCT-118: The Impact of Bifurcation Stenting Techniques on the Clinical Events: the Stratified Analysis of 2,510 Bifurcated Lesions According to MADS Classification in the Global LEADERS Trial Presenter: Michael A. Kutcher, Tullio Palmerini, Norihiro Kogame September 21, 2018
News Conference News TCT 2018 Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO Todd Neale September 21, 2018
Presentation TCT 2018 TCT-92: Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials Presenter: Alexandre Abizaid, Didier Carrié, David E. Kandzari September 21, 2018
Presentation TCT 2018 TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial Presenter: Alexandre Abizaid, Didier Carrié, Julia Ellert September 21, 2018
Presentation TCT 2018 Pivotal Clinical Trial of a Novel All-in-one Integrated System for Precise Transseptal Puncture and Simplified Left Atrial Navigation Presenter: Karl-Heinz Kuck September 21, 2018
Presentation TCT 2018 TCT-64: Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial Presenter: Antonio L. Bartorelli, David G. Rizik, Ricardo A. Costa September 21, 2018
Presentation TCT 2018 TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial Presenter: Antonio L. Bartorelli, David G. Rizik, Dean J. Kereiakes September 21, 2018
Presentation TCT 2018 TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial Presenter: Antonio L. Bartorelli, David G. Rizik, Patrick W. Serruys September 21, 2018
Presentation TCT 2018 TCT-53: Role of Single OCT Morphological Variable in the CLIMA Trial (Relationship between Coronary pLaque morphology of the left anterIor descending artery and long terM clinicAl outcome) Presenter: John A. Ambrose, Farouc A Jaffer, Enrico Romagnoli September 21, 2018
Presentation TCT 2018 Update of the NeoVas BRS Clinical Trials Presenter: Runlin Gao, Martin B. Leon, Yaling Han September 21, 2018
Presentation TCT 2018 Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber) Presenter: Juan F. Granada September 21, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018